5 stories mentioning AMPHUpdated 36d ago
Every FINWIRES story that references AMPH, newest first.
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
Amphastar Pharmaceuticals (AMPH) has an average rating of hold and mean price target of $22, according to analysts polled by FactSet.Price: $21.37, Change: $+0.51, Percent Change: +2.44%
(Updates with prior rating and price target as well as analyst averages.)Amphastar Pharmaceuticals (AMPH) has an average rating of hold and mean price target of $22, according to analysts polled by FactSet.
Amphastar Pharmaceuticals (AMPH) shares were falling over 4% in late Thursday trading after Wells Fargo downgraded the stock to equal-weight from overweight, and cut its price target to $19 from $30.Trading volume stood at more than 448,000 shares, compared with a daily average of about 592,000.Price: $17.43, Change: $-0.89, Percent Change: -4.86%
Amphastar Pharmaceuticals (AMPH) has an average rating of hold and mean price target of $23.33, according to analysts polled by FactSet.
Amphastar Pharmaceuticals (AMPH) has an average rating of overweight and mean price target of $26.86, according to analysts polled by FactSet.
